首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1316279

全球子宮內膜消融器械市場 - 2023-2030 年

Global Endometrial Ablation Devices Market - 2023-2030

出版日期: 2023年07月27日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年，全球子宮內膜消融器市場規模達到35 億美元，預計到2030 年將實現54 億美元的豐厚成長。在預測期內（2023-2030 年），全球子宮內膜消融器械市場的複合年成長率預計將達到5.6%。

子宮內膜消融器之所以重要，是因為它能有效治療月經出血過多或經期延長的婦女，一般稱為月經過多。月經過多會造成身體不適、精神痛苦和日常活動中斷，從而對婦女的生活品質產生負面影響。

子宮內膜消融裝置為希望保留子宮或避免大手術危害的婦女提供了子宮切除術之外的一種非手術選擇。它能讓患者在無需接受侵入性更強的手術的情況下治療自己的問題。

市場動態

子宮內膜癌發病率上升

子宮內膜癌發病率的上升是幫助市場在預測期內進一步成長的重要關鍵驅動因素之一。例如，根據《2022 年美國社區調查》更新的情況說明書，美國有超過60 萬名子宮內膜癌倖存者。根據同一資料來源，預計2022 年將發現約65,950 例新的子宮體癌（子宮體癌或子宮體癌）病例。因此，子宮內膜癌發病率的上升預計將推動子宮內膜消融設備需求的成長。

婦科疾病發病率上升

女性宮頸癌、月經過多、異常陰道出血和多囊卵巢綜合症（POCD）等婦科疾病發病率的上升是推動市場成長的主要因素。根據世界衛生組織2022 年2 月的最新數據，宮頸癌是全球婦女第四大常見癌症，到2020 年將有604 000 例新發病例和342 000 例死亡病例。到2020 年，中低收入國家的新增病例和死亡人數佔全球的近90%。因此，在預測期內，婦科疾病發病率的增加預計將推動市場成長。

子宮內膜消融術的相關風險

雖然不常見，但在手術過程中或手術後不久可能會出現以下風險。子宮深部損傷，如子宮肌層穿孔（撕裂）或燒傷；腹部器官損傷，如腸或膀胱穿孔（撕裂）或燒傷感染；陰道、外陰和皮膚燒傷出血（失血）；空氣或氣體栓塞（血管中的氣泡）。

COVID-19 影響分析

在COVID-19 流行期間，所有門診治療都被推遲或限制，以盡量減少病毒傳播的危險，因為大多數慢性療法都被認為是自願的。根據2022 年9 月發表在《施普林格期刊》上的一篇文章，在COVID-19 大流行期間，子宮內膜異位症患者的治療次數受到限制，尤其是在第一次封鎖期間。

子宮內膜異位症門診量減少了37%，子宮內膜異位症手術量減少了90%。因此，在COVID-19 期間，子宮內膜諮詢和外科手術的減少對大流行初期的市場成長產生了重大影響。

俄烏戰爭影響分析

據估計，俄烏衝突對全球子宮內膜消融器市場的影響不大，原因是該地區子宮內膜消融器的普及率較低，而且沒有主要的市場參與者。不過，在預測期內，子宮內膜消融器的進出口對全球子宮內膜消融器市場成長的影響預計不大。

Market Overview

The global endometrial ablation device market reached US$ 3.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 5.4 billion by 2030. The global endometrial ablation devices market is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

Endometrial ablation devices are significant because they can effectively treat women who have excessive or extended menstrual bleeding, generally known as menorrhagia. Menorrhagia can have a negative influence on a woman's quality of life by producing physical discomfort, mental anguish, and interruption of everyday activities.

Endometrial ablation devices provide a non-surgical option to hysterectomy for women who want to keep their uterus or avoid the hazards of major surgery. It enables patients to treat their problems without having to undergo more intrusive surgery.

Market Dynamics

Rising Prevalence of Endometrial Cancer

The rising prevalence of endometrial cancer is one of the significant key drivers that help the market to grow further during the forecast period. For instance, according to the American Community Survey 2022 updated factsheet, there were over 600,000 endometrial cancer survivors in the United States. According to the same source, around 65,950 new cases of uterine body cancer (uterine body or corpus) are projected to be detected in 2022. As a result, the rising incidence of endometrial cancer is predicted to drive up demand for endometrial ablation devices.

Rise in the Prevalence of Gynaecological Disorders

The rise in the prevalence of gynaecological disorders such as cervical cancer, menorrhagia, abnormal vaginal bleeding, and POCD (polycystic ovarian disease) in women is a major factor driving market growth. Cervical cancer is the fourth most common cancer in women worldwide, according to World Health Organization updates in February 2022, with 604 000 new cases and 342 000 deaths by 2020. Low- and middle-income countries accounted for nearly 90% of new cases and deaths globally by 2020. As a result, the increasing prevalence of gynaecological diseases is expected to drive market growth during the forecast period.

Risks Associated With Endometrial Ablation

While uncommon, the following risks may occur during or shortly after the surgery. Deep uterine damage, such as perforation (tear) or burn beyond the uterine muscle layer, injury to the abdominal organs, such as bowel or bladder perforation (tears) or burns infection, burn harm to the vagina, vulva, and skin haemorrhage (blood loss), embolism of air or gas (air bubble in the blood vessels) can occur.

COVID-19 Impact Analysis

During the COVID-19 epidemic, all outpatient treatments were postponed or limited to minimise the danger of viral transmission, as most chronic therapies were deemed voluntary. According to an article published in the Springer Journal in September 2022, during the COVID-19 pandemic, the number of treatments for endometriosis patients was limited, particularly during the first lockdown.

There was a 37% decrease in the endometriosis outpatient department and a 90% decrease in surgical endometriosis. Thus, the drop in endometrial consultations and surgical operations during COVID-19 had a substantial influence on market growth during the pandemic's early phases.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global endometrial ablation devices market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of endometrial ablation devices is expected to have little influence over the global endometrial ablation devices market growth over the forecast period.

Segment Analysis

The global endometrial ablation devices market is segmented based on device type, end user and region.

Hysteroscopy Devices from Device Type Segment Accounts for 23.6% of Market Share

The hysteroscopy devices from the device type segment with around 23.6%. The use of a hysteroscopy instrument offers a real-time picture of the uterine cavity, allowing the clinician to correctly plan and direct the endometrial ablation operation. The hysteroscope aids in visualising the position and extent of the endometrial tissue to be treated, allowing for accurate targeting and total coverage during the ablation procedure. Hysteroscopy instruments allow for continuous monitoring of the treatment progress during the endometrial ablation operation.

For instance, in November 2022, in India, Medtronic introduced a novel instrument for diagnostic and surgical hysteroscopy. India Medtronic, a fully owned subsidiary of Medtronic plc, announced the debut of the TruClear system, a mechanical hysteroscopic tissue removal device used for the safe and effective treatment of intrauterine abnormalities (IUA). Fibroids, polyps, retained products of conception, adhesions, malignancies, or hyperplasia are all examples of IUA.

Geographical Analysis

North America Accounted for Approximately 38.2% of the Market Share

North America is estimated to hold about 38.2% of the total market share throughout the forecast period due to the rising prevalence of gynaecological disorders such as PCOS, abnormal uterine bleeding (AUB), menorrhagia, and escalating cases of cancer such as uterine cancer among women is driving the North American endometrial ablation devices market, which is expected to grow positively.

Competitive Landscape

The major global players in the endometrial ablation devices market include: Medtronic, Boston Scientific Corporation, Cooper Surgical, Minerva Surgical, Ethicon, KARL STORZ GmbH & Co. KG, Richard Wolf GmbH, AngioDynamics Inc., Smith & Nephew PLC, Olympus Corporation and others.

Why Purchase the Report?

To visualize the global endometrial ablation devices market segmentation based on device type, end user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the endometrial ablation devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global endometrial ablation devices market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Device Type
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Endometrial Cancer
  - 4.1.1.2. Rise in Approvals
- 4.1.2. Restraints
  - 4.1.2.1. Risks Associated With Endometrial Ablation
- 4.1.3. Opportunity
  - 4.1.3.1. Increasing technological advancements in endometrial ablation devices
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Device Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Hydrothermal ablators *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Thermal balloon ablators
7.4. Hysteroscopy devices
7.5. Cryoablation devices
7.6. Radiofrequency endometrial ablation devices
7.7. Microwave endometrial ablators
7.8. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospital *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory surgical centres
8.4. Specialty Clinics
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. U.K.
  - 9.3.5.3. France
  - 9.3.5.4. Spain
  - 9.3.5.5. Italy
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Medtronic*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Boston Scientific Corporation
11.3. Cooper Surgical
11.4. Minerva Surgical
11.5. Ethicon
11.6. KARL STORZ GmbH & Co. KG
11.7. Richard Wolf GmbH
11.8. AngioDynamics Inc.
11.9. Smith & Nephew PLC
11.10. Olympus Corporation

LIST NOT EXHAUSTIVE